GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness
Open accessThe DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Abstract
Glycogen synthase kinase 3β (GSK3β), originally described as a negative regulator of glycogen synthesis, is a molecular hub linking numerous signaling pathways in a cell. Specific GSK3β inhibitors have anti-depressant effects and reduce depressive-like behavior in animal models of depression. Therefore, GSK3β is suggested to be engaged in the pathogenesis of major depressive disorder, and to be a target and/or modifier of anti-depressants’ action. In this review, we discuss abnormalities in the activity of GSK3β and its upstream regulators in different brain regions during depressive episodes. Additionally, putative role(s) of GSK3β in the pathogenesis of depression and the influence of anti-depressants on GSK3β activity are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment with GSK-3β inhibitors reduces the production of QUIN and subsequently alleviates depressive, anxious, and aggressive behaviors in animal models (137).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [137]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, post-mortem studies have reported elevated GSK-3β mRNA levels in the hippocampus of patients with major depression.”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [137]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 1×
“Systemic injection of pro-inflammatory cytokines induces depression-like phenotype [132].”
BackgroundWnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583 · cited 1×
“β-catenin, a multifunctional protein downstream to WNT signaling [112], is another factor putatively regulating stress resilience development [113].”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 1×
“Both of these pathways reduce the activity of GSK3β, but only PI3K/AKT acts through phosphorylation of Ser9 [92,93].”
BackgroundMalhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492 · cited 1×
“These findings resulted in the monoaminergic hypothesis of the MDD pathogenesis, which assumes that MDD is caused by a reduction in noradrenaline (NA) and serotonin (5-HT) neurotransmission [4].”
BackgroundSubgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · cited 1×
“In 1997, a reduction in the cortical volume of patients suffering from different types of depression was linked to decreased brain activity [74].”
BackgroundGut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460 · cited 1×
“It is worth noting that multiple research groups have reported that the manipulation of the gastrointestinal tract microbiome status affects anxiety- and depressive-like behaviors in rodents, and that the administration of probiotics reduces such behaviors [151].”
BackgroundKrishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1×
“It corresponds to results of post mortem studies of human brains where an increased level of BDNF in nucleus accumbens has been detected [90].”
ResultA molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 2×
“The discovery that GSK3β is a direct target of lithium action [63] has raised the possibility that lithium exerts its effects through the odulating activity of the kinase.”
BackgroundRole of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256 · cited 1×
“The gut microbiota play an active role in immunity and inflammation [152].”
BackgroundEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129 · cited 2×
“On the other hand, the levels of BDNF in structures of the mesolimbic system, such as nucleus accumbens and ventral tegmental area, are increased due to chronic stress [89], which promotes a pro-depressant phenotype.”
BackgroundMarciniak, S. J., Yun, C. Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., Nagata, K., Harding, H. P., & Ron, D. (2004) · Genes & Development · doi:10.1101/gad.1250704 · Cited by 2,001 · cited 3×
“Under stress conditions, the pro-apoptotic CHOP protein is regulated by GSK3.”
BackgroundThe brain reward circuitry in mood disorders
Russo, S. J., & Nestler, E. J. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3381 · Cited by 1,870
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768 · cited 1×
“Whereas phosphorylation of the residue Tyr216 occurs during the GSK3β translation process and results in a synthesis of the fully activated kinase, Ser9 phosphorylation seems to be the main regulatory modification during the enzyme lifespan [12].”
BackgroundRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 1×
“Anti-inflammatory drugs may have anti-depressant effects in MDD patients [130,131].”
BackgroundHippocampal volume and depression: a meta-analysis of MRI studies
Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590 · cited 1×
“The decreased volume of the hippocampus has also been found in MDD patients in comparison to healthy individuals in an MRI-based study [78].”
ResultNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.009 · Cited by 1,496
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 2×
“Simultaneously, atrophy of the PFC and hippocampus, and increased synaptogenesis in limbic regions, are observed in depressed individuals [75,77,81,82].”
BackgroundThe role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378 · cited 3×
“CRF is probably involved in vulnerability to mood disorders in animal models of depression, which revealed a decreased methylation of CRF promoter upon social stressors [125].”
BackgroundNew regulators of NF-κB in inflammation
Ghosh, S., & Hayden, M. S. (2008) · Nature Reviews Immunology · doi:10.1038/nri2423 · Cited by 1,334 · cited 3×
“GSK3β phosphorylates two members of NF-κB complex: p65 (RelA) and p105 (NF-κB1) [148,149].”
BackgroundLithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · cited 1×
“Lithium inhibits both isozymes of GSK3 directly [198] by competition with magnesium ions [199].”
BackgroundHomayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · cited 1×
“The consequent ketamine-induced inhibition of the interneurons results in disinhibition of the pyramidal cells [205].”
BackgroundHow NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD).
Luscher, C., & Malenka, R. C. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005710 · Cited by 1,110 · cited 1×
“Whereas AMPARs are responsible for membrane depolarization upon glutamate binding, NMDARs, conducting calcium current, are directly associated with neuroplasticity [24].”
BackgroundThe endoplasmic reticulum and the unfolded protein response
Malhotra, J. D., & Kaufman, R. J. (2007) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.09.003 · Cited by 986 · cited 1×
“Activation of UPR leads to restoration of the ER homeostasis or if it cannot be achieved, to apoptosis [106].”
BackgroundAn Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941 · cited 1×
“Anti-inflammatory drugs may have anti-depressant effects in MDD patients [130,131].”
BackgroundSetiawan, E., Wilson, A. A., Mizrahi, R., Rusjan, P. M., Miler, L., Rajkowska, G., Suridjan, I., Kennedy, J. L., Rekkas, P. V., Houle, S., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2427 · Cited by 939 · cited 1×
“Elevated cytokine levels are accompanied by microglia activation/hyper-reactivity in PFC, cingulate cortex, and insula of depressed patients [137,138].”
BackgroundPharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939 · cited 2×
“3 nM and 19–35 nM [164], respectively), enhances phosphorylation of the GSK3β Ser9 residue [167].”
BackgroundEmbi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Woodgett, J. R., & Mills, G. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413597 · Cited by 830
Structure of an IκBα/NF-κB Complex
Jacobs, M. D., & Harrison, S. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81698-0 · Cited by 821
Repeated Stress Induces Dendritic Spine Loss in the Rat Medial Prefrontal Cortex
Radley, J. J., Rocher, A. B., Miller, M., Janssen, W. G. M., Liston, C., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhi104 · Cited by 820 · cited 16×
“It has been found that the deletion of D3R in DAT knockdown mice restores novelty-induced GSK3β activation in the medial PFC.”
BackgroundInfluentialA Review of the Pharmacological and Clinical Profile of Mirtazapine
Anttila, S. A. K., & Leinonen, E. V. J. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00198.x · Cited by 795 · cited 1×
“Additionally, mianserin is a NET inhibitor [187].”
Beaulieu, J.-M., Sotnikova, T. D., Yao, W.-D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 793 · cited 3×
“Lithium can also activate AKT and, thus, inhibit GSK3 indirectly [158,200,201].”
BackgroundEMBI, N., RYLATT, D. B., & COHEN, P. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06059.x · Cited by 779
Hodes, G. E., Pfau, M. L., Leboeuf, M., Golden, S. A., Christoffel, D. J., Bregman, D., Rebusi, N., Heshmati, M., Aleyasin, H., Warren, B. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415191111 · Cited by 692 · cited 8×
“An increased level of TNFα in non-recovered mice displaying depression-like behavior is accompanied by greater hippocampal activation of GSK3, higher levels of interleukin-17A and -23, and lower level of the BBB tight junction proteins in comparison to recovered and control animals [70].”
BackgroundInfluentialRaadsheer, F. C., Hoogendijk, W. J. G., Stam, F. C., Tilders, F. J. H., & Swaab, D. F. (2008) · Neuroendocrinology · doi:10.1159/000126778 · Cited by 667 · cited 1×
“An increased number of CRF-neurons has been found in the paraventricular nucleus of depressed patients [124].”
BackgroundPham, K., Nacher, J., Hof, P. R., & McEwen, B. S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02513.x · Cited by 657 · cited 1×
“Additionally, in the adult rodent brain, repeated stress reduces the neurogenesis ratio and the total neurons number in the dentate gyrus [85].”
BackgroundModulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation.
Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F., & Woodgett, J. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05715.x · Cited by 629 · cited 1×
“The activity of GSK3β is regulated positively and negatively by phosphorylation on Tyr216 and Ser9, respectively [10,11].”
Backgroundβ-Catenin destruction complex: insights and questions from a structural perspective
Kimelman, D., & Xu, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210055 · Cited by 628 · cited 1×
“This results in GSK3β-dependent phosphorylation of β-catenin and leads to its subsequent proteasomal degradation [115].”
BackgroundDnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens
LaPlant, Q., Vialou, V., Covington, H. E., Dumitriu, D., Feng, J., Warren, B. L., Maze, I., Dietz, D. M., Watts, E. L., Iñiguez, S. D., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2619 · Cited by 612 · cited 1×
“Such a decrease in DNA methylation is in line with the altered expression of DNA methyltransferase 3a (DNMT3a) in the brain structures of depressed animals [126].”
BackgroundNuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior
Koo, J. W., Russo, S. J., Ferguson, D., Nestler, E. J., & Duman, R. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910658107 · Cited by 607
Vallières, L., Campbell, I. L., Gage, F. H., & Sawchenko, P. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00486.2002 · Cited by 600 · cited 1×
“Pro-inflammatory cytokines, such as IL-6, can also be produced by astrocytes, and this can inhibit neurogenesis in the hippocampus [139].”
BackgroundPathogenesis of depression: Insights from human and rodent studies
Ménard, C., Hodes, G. E., & Russo, S. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.053 · Cited by 593 · cited 1×
“Changes can also be observed in other brain regions, such as the ventral tegmental area [84].”
BackgroundThe interaction between Stargazin and PSD-95 regulates AMPA receptor surface trafficking
Bats, C., Groc, L., & Choquet, D. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.030 · Cited by 590 · cited 8×
“In contrast to LTP, LTD is a process of weakening of synapses in which AMPARs are internalized due to the modest-[Ca2+]c-induced activation of protein phosphatases, including calcineurin.”
BackgroundInfluentialBrain-Derived Neurotrophic Factor/TrkB Signaling in Memory Processes
Yamada, K., & Nabeshima, T. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.91.267 · Cited by 585 · cited 1×
“All the above changes might be linked to the altered activity of BDNF, a neurotrophic factor that supports the survival of existing neurons and improves the growth of new neurons and synapses [86].”
BackgroundMitogen inactivation of glycogen synthase kinase-3 β in intact cells via serine 9 phosphorylation
Stambolic, V, & Woodgett, J. R. (1994) · Biochemical Journal · doi:10.1042/bj3030701 · Cited by 581
Alterations in 5-HT 1B Receptor Function by p11 in Depression-Like States
Svenningsson, P., Chergui, K., Rachleff, I., Flajolet, M., Zhang, X., Yacoubi, M. E., Vaugeois, J.-M., Nomikos, G. G., & Greengard, P. (2006) · Science · doi:10.1126/science.1117571 · Cited by 572 · cited 2×
“p11 is downregulated in depressed patients [100], and overexpression of p11 has the anti-depressant-like effect [100].”
BackgroundSteiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568 · cited 1×
“Elevated cytokine levels are accompanied by microglia activation/hyper-reactivity in PFC, cingulate cortex, and insula of depressed patients [137,138].”
BackgroundChalecka-Franaszek, E., & Chuang, D.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8745 · Cited by 542 · cited 1×
“Lithium can also activate AKT and, thus, inhibit GSK3 indirectly [158,200,201].”
BackgroundSignaling pathways underlying the rapid antidepressant actions of ketamine
Duman, R. S., Li, N., Liu, R.-J., Duric, V., & Aghajanian, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.044 · Cited by 537 · cited 3×
“Both the TrkB/MEK/ERK and TrkB/PI3K/AKT pathways can activate mTOR and inactivate GSK3β [13,204].”
BackgroundAkt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 522 · cited 1×
“Furthermore, the anti-depressant effect of mianserin and mirtazapine can be attributed to the downregulation of 5-HT2AR expression [189], which activates GSK3β via inhibition of AKT [190].”
BackgroundLithium Inhibits Glycogen Synthase Kinase-3 by Competition for Magnesium
Ryves, W. J., & Harwood, A. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4169 · Cited by 493 · cited 1×
“Lithium inhibits both isozymes of GSK3 directly [198] by competition with magnesium ions [199].”
BackgroundPhosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation
Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B., et al. (2008) · Science · doi:10.1126/science.1156037 · Cited by 484
MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J.-M., & Kellermann, O. (2010) · Science · doi:10.1126/science.1193692 · Cited by 480 · cited 7×
“However, in contrast to the depression-like effect of sertraline in cancer cells, its anti-depressant properties could be explained by the high affinity of sertraline to SERT (Ki is about 0.4 nM [164]).”
BackgroundInfluentialGSK3 and its interactions with the PI3K/AKT/mTOR signalling network
Hermida, M. A., Dinesh Kumar, J., & Leslie, N. R. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.06.003 · Cited by 477
Izquierdo, A., Wellman, C. L., & Holmes, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0474-06.2006 · Cited by 459 · cited 16×
“It has been found that the deletion of D3R in DAT knockdown mice restores novelty-induced GSK3β activation in the medial PFC.”
BackgroundInfluentialIntegrin-linked kinase (ILK) and its interactors
Wu, C., & Dedhar, S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108077 · Cited by 447
Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.026 · Cited by 443 · cited 9×
“An increased level of TNFα in non-recovered mice displaying depression-like behavior is accompanied by greater hippocampal activation of GSK3, higher levels of interleukin-17A and -23, and lower level of the BBB tight junction proteins in comparison to recovered and control animals [70].”
BackgroundInfluentialResilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice
Elliott, E., Ezra-Nevo, G., Regev, L., Neufeld-Cohen, A., & Chen, A. (2010) · Nature Neuroscience · doi:10.1038/nn.2642 · Cited by 436 · cited 1×
“CRF is probably involved in vulnerability to mood disorders in animal models of depression, which revealed a decreased methylation of CRF promoter upon social stressors [125].”
BackgroundRegulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium
De Sarno, P., Li, X., & Jope, R. S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00215-0 · Cited by 434 · cited 1×
“Lithium can also activate AKT and, thus, inhibit GSK3 indirectly [158,200,201].”
BackgroundO'Brien, W. T., Harper, A. D., Jové, F., Woodgett, J. R., Maretto, S., Piccolo, S., & Klein, P. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4753-03.2004 · Cited by 415 · cited 1×
“Moreover, heterozygous loss of Gsk3β causes behavioral defects that mimic the action of lithium [67], whereas transgenic expression of Gsk3β in Gsk3β+/− heterozygotes reverses these defects [68].”
BackgroundMicroRNAs in neuronal function and dysfunction
Im, H.-I., & Kenny, P. J. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.01.004 · Cited by 399 · cited 1×
“β-catenin regulates the expression of various miRNA species, which play a role in neuroplasticity [117].”
BackgroundThe mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
Jernigan, C. S., Goswami, D. B., Austin, M. C., Iyo, A. H., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.05.010 · Cited by 386 · cited 1×
“Post mortem studies of PFC tissue from patients suffering from depression have shown an increase in REDD1 [101] and a reduction in mTOR protein levels [102].”
BackgroundRole of GSK3β in behavioral abnormalities induced by serotonin deficiency
Beaulieu, J.-M., Zhang, X., Rodriguiz, R. M., Sotnikova, T. D., Cools, M. J., Wetsel, W. C., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711496105 · Cited by 368 · cited 5×
“It has also been shown that prolonged learned helplessness is reversible and is maintained by abnormally active GSK3, whereas treatment with TDZD-8, non-ATP-competitive GSK3 inhibitor, reverses the impaired recovery from learned helplessness [70].”
BackgroundInfluentialAnhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens
Lim, B. K., Huang, K. W., Grueter, B. A., Rothwell, P. E., & Malenka, R. C. (2012) · Nature · doi:10.1038/nature11160 · Cited by 368 · cited 1×
“These changes are correlated with anxiety-like behavior and anhedonia [83].”
BackgroundBDNF release is required for the behavioral actions of ketamine
Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., & Duman, R. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu033 · Cited by 368
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
Beaulieu, J.-M., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362
Binding of antidepressants to human brain receptors: focus on newer generation compounds
Cusack, B., Nelson, A., & Richelson, E. (1994) · Psychopharmacology · doi:10.1007/bf02244985 · Cited by 349 · cited 1×
“3 nM, 20–37 nM [164], and 80–150 nM [165], respectively).”
What Are the bona fide GSK3 Substrates?
Sutherland, C. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/505607 · Cited by 345 · cited 1×
“is regulated by c-Myc, a target of GSK3β [128].”
BackgroundPrickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5216-05.2006 · Cited by 341 · cited 1×
“It has been demonstrated that GSK3β+/− heterozygotic mice are less responsive to amphetamine [158], whereas mice expressing a constitutively active GSK3βmutant develop a locomotor hyperactivity phenotype recapitulating the hyper-dopaminergy conditions [161].”
BackgroundIssler, O., Haramati, S., Paul, E. D., Maeno, H., Navon, I., Zwang, R., Gil, S., Mayberg, H. S., Dunlop, B. W., Menke, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.042 · Cited by 318 · cited 2×
“Moreover, miR16 regulates the expression of 5-HT transporter (SERT) [121], while miR135a is associated with the regulation of the expression of SERT and 5-HT1AR [122].”
BackgroundGould, T. D., Einat, H., Bhat, R., & Manji, H. K. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004535 · Cited by 314 · cited 1×
“Hyper-dopaminergic mice display concomitant novelty-induced locomotor hyperactivity [157], which could be reduced by GSK3 inhibitors in the DAT lacking mice, and in amphetamine-treated normal mice [158,159].”
BackgroundAstrocytic abnormalities and global DNA methylation patterns in depression and suicide
Nagy, C., Suderman, M., Yang, J., Szyf, M., Mechawar, N., Ernst, C., & Turecki, G. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.21 · Cited by 301 · cited 1×
“This has been confirmed by studies showing decreased expression of the glial fibrillary acidic protein (GFAP, an astrocytic cell marker) in the PFC of depressed patients [141].”
BackgroundWohleb, E. S., McKim, D. B., Shea, D. T., Powell, N. D., Tarr, A. J., Sheridan, J. F., & Godbout, J. P. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.029 · Cited by 300 · cited 1×
“This leads to increased permeability of the BBB and enhanced monocyte trafficking from the bloodstream to the central nervous system, which might strengthen the inflammatory reaction in the brain [142].”
BackgroundIn Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain
Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300
Prolonged behavioral stress enhances synaptic connectivity in the basolateral amygdala
Vyas, A., Jadhav, S., & Chattarji, S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.003 · Cited by 299 · cited 2×
“Simultaneously, atrophy of the PFC and hippocampus, and increased synaptogenesis in limbic regions, are observed in depressed individuals [75,77,81,82].”
BackgroundTNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
Cheng, Y., Desse, S., Martinez, A., Worthen, R. J., Jope, R. S., & Beurel, E. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.003 · Cited by 292 · cited 9×
“It has also been shown that prolonged learned helplessness is reversible and is maintained by abnormally active GSK3, whereas treatment with TDZD-8, non-ATP-competitive GSK3 inhibitor, reverses the impaired recovery from learned helplessness [70].”
BackgroundResultInfluentialBeurel, E., Song, L., & Jope, R. S. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.47 · Cited by 288 · cited 1×
“It has been shown that inhibition of GSK3 is necessary for the rapid anti-depressant action of ketamine in mice [209], whereas knock-in mice with constitutively active GSK3β are insensitive to the anti-depressant action of ketamine [208].”
BackgroundRelapse Following Successful Electroconvulsive Therapy for Major Depression: A Meta-Analysis
Jelovac, A., Kolshus, E., & McLoughlin, D. M. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.149 · Cited by 287 · cited 1×
“Additionally, electroconvulsive therapy, conducted for the first time in 1938, is still widely used in the treatment of MDD, especially in its drug-refractory form [5].”
BackgroundKaidanovich-Beilin, O., Milman, A., Weizman, A., Pick, C. G., & Eldar-Finkelman, H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.008 · Cited by 276 · cited 2×
“Intracerebroventricular injection of a novel GSK3β substrate competitive inhibitor, L803-mts, has reduced the duration of immobility in the forced swim test in mice, in comparison to control animals [73].”
BackgroundREDD1 is essential for stress-induced synaptic loss and depressive behavior
Ota, K. T., Liu, R.-J., Voleti, B., Maldonado-Aviles, J. G., Duric, V., Iwata, M., Dutheil, S., Duman, C., Boikess, S., Lewis, D. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3513 · Cited by 267 · cited 8×
“Additionally, in human breast adenocarcinoma, sertraline stimulates overexpression of REDD1 and inhibits mTOR [183].”
BackgroundInfluentialLiu, R.-J., Fuchikami, M., Dwyer, J. M., Lepack, A. E., Duman, R. S., & Aghajanian, G. K. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.128 · Cited by 256 · cited 1×
“In turn, an ATP-competitive GSK3β inhibitor SB216763 has been found to increase anti-depressant responses in the forced swim test [71], whereas SAR502250 improved the stress-induced physical state in the chronic mild stress test in mice [72].”
BackgroundInflammatory T helper 17 cells promote depression-like behavior in mice
Beurel, E., Harrington, L. E., & Jope, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.021 · Cited by 254 · cited 2×
“Additionally, it has been shown that IL-6 induces the production of inflammatory T helper 17 cells (Th17), thus increasing levels of these cells in the brain during depression-like states [143].”
BackgroundCircuit Mechanisms of Reward, Anhedonia, and Depression
Höflich, A., Michenthaler, P., Kasper, S., & Lanzenberger, R. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy081 · Cited by 253 · cited 1×
“They are caused by a disrupted interplay between different brain structures, such as ventral tegmental area, nucleus accumbens, and cingulate cortex, which can be grouped in the so-called reward circuit [45].”
Background[Treatment of depressive states with an iminodibenzyl derivative (G 22355)].
KUHN, R. (1957) · PubMed · Cited by 242
Dopamine Receptors and Neurodegeneration
Claudia, R., Israel, C., & Benjamín, F. (2015) · Aging and disease · doi:10.14336/ad.2015.0330 · Cited by 241 · cited 1×
“Stimulation of Dopamine Receptor 1 (D1R) and Dopamine Receptor 3 (D3R) activates adenylyl cyclase and inhibits GSK3β through PKA and AKT action [32].”
BackgroundBi-phasic change in BDNF gene expression following antidepressant drug treatment
Coppell, A. L., Pei, Q., & Zetterström, T. S. C. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00077-7 · Cited by 241 · cited 1×
“Moreover, 24 h after the single injection, the BDNF expression level did not differ from control, whereas 24 h after the last injection of the chronic treatment, the expression level of BDNF was significantly higher than in control [181].”
Backgroundβ-catenin mediates stress resilience through Dicer1/microRNA regulation
Dias, C., Feng, J., Sun, H., Shao, N. Y., Mazei-Robison, M. S., Damez-Werno, D., Scobie, K., Bagot, R., LaBonté, B., Ribeiro, E., et al. (2014) · Nature · doi:10.1038/nature13976 · Cited by 240 · cited 1×
“β-catenin, a multifunctional protein downstream to WNT signaling [112], is another factor putatively regulating stress resilience development [113].”
BackgroundBeaulieu, J.-M. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110011 · Cited by 238 · cited 1×
“Dopamine Receptor 2 (D2R) inhibits AKT via activation of β-arrestin 2/PP2A complex and leads to GSK3β activation [33].”
BackgroundVoorhees, J. L., Tarr, A. J., Wohleb, E. S., Godbout, J. P., Mo, X., Sheridan, J. F., Eubank, T. D., & Marsh, C. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058488 · Cited by 236 · cited 1×
“Depression-like behavior in rodents correlates with increased levels of pro-inflammatory cytokines: interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor α (TNFα) [133,134], and decreased levels of anti-inflammatory interleukin-10 (IL-10) [135].”
BackgroundStress-induced plasticity and functioning of ventral tegmental dopamine neurons
Douma, E. H., & de Kloet, E. R. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.015 · Cited by 229 · cited 1×
“It has been hypothesized that these opposing outcomes might be due to a different nature of the stressors, the heterogeneity of ventral tegmental area cells, or the time of day when the experiments were performed [51].”
BackgroundBeurel, E., & Jope, R. S. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-9 · Cited by 228 · cited 3×
“GSK3β promotes STAT3 activation and, thus, stimulates the expression of IL-6.”
BackgroundInfluentialJourdi, H., Hsu, Y.-T., Zhou, M., Qin, Q., Bi, X., & Baudry, M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6078-08.2009 · Cited by 226 · cited 1×
“Ketamine treatment leads to increased excitability of disinhibited glutamatergic neurons and may stimulate BDNF release [206].”
BackgroundPolter, A., Beurel, E., Yang, S., Garner, R., Song, L., Miller, C. A., Sweatt, J. D., McMahon, L., Bartolucci, A. A., Li, X., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.43 · Cited by 225
BDNF promoter methylation and suicidal behavior in depressive patients
Kang, H.-J., Kim, J.-M., Lee, J.-Y., Kim, S.-Y., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Kim, H.-R., Shin, M.-G., & Yoon, J.-S. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.08.001 · Cited by 218 · cited 1×
“Moreover, an increased risk of suicide in humans is correlated with hyper-methylation of the BDNF promoter [127].”
BackgroundEldar-Finkelman, H., Seger, R., Vandenheede, J. R., & Krebs, E. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.987 · Cited by 214
Chronic stress triggers social aversion via glucocorticoid receptor in dopaminoceptive neurons
Barik, J., Marti, F., Morel, C., Fernandez, S. P., Lanteri, C., Godeheu, G., Tassin, J.-P., Mombereau, C., Faure, P., & Tronche, F. (2013) · Science · doi:10.1126/science.1226767 · Cited by 214 · cited 1×
“It has been shown that chronic social defeat stress enhances the phasic firing rate of the ventral tegmental area neurons in defeated rodents [49].”
BackgroundRemodeling of Hippocampal Spine Synapses in the Rat Learned Helplessness Model of Depression
Hajszan, T., Dow, A., Warner-Schmidt, J. L., Szigeti-Buck, K., Sallam, N. L., Parducz, A., Leranth, C., & Duman, R. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.031 · Cited by 210
Karege, F., Perroud, N., Burkhardt, S., Schwald, M., Ballmann, E., La Harpe, R., & Malafosse, A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.036 · Cited by 208 · cited 2×
“This suggests a role of GSK3β in MDD but not in suicide per se [40,41].”
BackgroundInoculation stress hypothesis of environmental enrichment.
Crofton, E. J., Zhang, Y., & Green, T. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.017 · Cited by 206 · cited 1×
“, found that the knockdown of GSK3β in the nucleus accumbens shell increases cocaine self-administration and depression-like behavior in social contact tests in rats [47,48].”
BackgroundGSK3B polymorphisms alter transcription and splicing in Parkinson's disease
Kwok, J. B. J., Hallupp, M., Loy, C. T., Chan, D. K. Y., Woo, J., Mellick, G. D., Buchanan, D. D., Silburn, P. A., Halliday, G. M., & Schofield, P. R. (2005) · Annals of Neurology · doi:10.1002/ana.20691 · Cited by 205 · cited 2×
“rs334558, a promoter SNP related with enhanced GSK3β transcription [57], is associated with remission upon anti-depressant drugs administration [60].”
BackgroundTyagarajan, S. K., Ghosh, H., Yévenes, G. E., Nikonenko, I., Ebeling, C., Schwerdel, C., Sidler, C., Zeilhofer, H. U., Gerrits, B., Muller, D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011824108 · Cited by 204 · cited 1×
“GSK3β phosphorylates gephyrin, which induces the formation of new GABAergic synapses [30].”
BackgroundVallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Oncotarget · doi:10.18632/oncotarget.21234 · Cited by 204
Xing, B., Li, Y.-C., & Gao, W.-J. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.005 · Cited by 196 · cited 7×
“Their action is associated with modulation of PKA, PKC, and PLC activity.”
BackgroundInfluentialBDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents
Mai, L., Jope, R. S., & Li, X. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00939.x · Cited by 195 · cited 3×
“BDNF is a ligand for tropomyosin receptor kinase B (TrkB), the stimulation of which leads to the activation of PI3K/AKT and ERK1/2 signaling pathways [91].”
BackgroundCouch, Y., Anthony, D. C., Dolgov, O., Revischin, A., Festoff, B., Santos, A. I., Steinbusch, H. W., & Strekalova, T. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.12.017 · Cited by 187 · cited 1×
“Furthermore, the anti-depressant effect of mianserin and mirtazapine can be attributed to the downregulation of 5-HT2AR expression [189], which activates GSK3β via inhibition of AKT [190].”
BackgroundATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression
Whitney, M. L., Jefferson, L. S., & Kimball, S. R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.079 · Cited by 184 · cited 8×
“Additionally, in human breast adenocarcinoma, sertraline stimulates overexpression of REDD1 and inhibits mTOR [183].”
BackgroundInfluentialInhibition of GSK3 by Wnt signalling – two contrasting models
Metcalfe, C., & Bienz, M. (2011) · Journal of Cell Science · doi:10.1242/jcs.091991 · Cited by 181 · cited 1×
“Additionally, upon WNT activation, a Frizzled-associated protein—low-density lipoprotein receptor-related protein 5 and 6 (LRP5/6), exposes its GSK3β pseudo-substrate motif (Pro-Pro-Pro-Ser-Pro-X-Ser) and inhibits GSK3β in a competitive manner [116].”
BackgroundKrishnan, V., Han, M.-H., Mazei-Robison, M., Iñiguez, S. D., Ables, J. L., Vialou, V., Berton, O., Ghose, S., Covington, H. E., Wiley, M. D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.003 · Cited by 176 · cited 2×
“In line with this, decreased AKT activity in the ventral tegmental area increases susceptibility to depressive-like behaviors in a rodent model [53].”
BackgroundGlycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00016 · Cited by 176
Cheng, Y., Pardo, M., Armini, R. D. S., Martinez, A., Mouhsine, H., Zagury, J.-F., Jope, R. S., & Beurel, E. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.012 · Cited by 174 · cited 3×
“Additionally, TDZD-8 attenuates an increased activation of NF-κB upon TLR4 stimulation [150], which indicates that GSK3 mediates a TLR4-related pro-inflammatory reaction associated with depression-like behavior.”
BackgroundWilkinson, M. B., Dias, C., Magida, J., Mazei-Robison, M., Lobo, M., Kennedy, P., Dietz, D., Covington, H., Russo, S., Neve, R., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0039-11.2011 · Cited by 170 · cited 4×
“Additionally, a similar pro-depression-like effect can be induced by GSK3β overexpression in the nucleus accumbens, while the expression of inactive GSK3β mutant promotes resilience to social defeat stress [46].”
BackgroundInfluentialGephyrin: a central GABAergic synapse organizer
Choii, G., & Ko, J. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.5 · Cited by 165 · cited 1×
“Its receptors, ionotropic GABAA and metabotropic GABAB receptors, group in inhibitory synapses together with gephyrin, a scaffolding protein [29].”
BackgroundGSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression
Pláteník, J., Fišar, Z., Buchal, R., Jirák, R., Kitzlerová, E., Zvěřová, M., & Raboch, J. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.12.001 · Cited by 161 · cited 1×
“The increase on GSK3β activity has also been found in platelets of depressed patients [42,43], whereas the GSK3β gene expression was upregulated in such brain structures as the frontal cortex, raphe, and hippocampus in the rat model of depression [44].”
BackgroundClinical experience with iproniazid (marsilid).
Ns, K. (1958) · PubMed · Cited by 160
Yao, H.-B., Shaw, P., Wong, C.-C., & Wan, D. C. (2002) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(02)00014-5 · Cited by 152 · cited 1×
“There are two isozymes of GSK3, α and β, and both are expressed at similar levels in the mouse brain [8].”
BackgroundREDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A–DDB1 ubiquitin ligase
Katiyar, S., Liu, E., Knutzen, C. A., Lang, E. S., Lombardo, C. R., Sankar, S., Toth, J. I., Petroski, M. D., Ronai, Z., & Chiang, G. G. (2009) · The EMBO Reports · doi:10.1038/embor.2009.93 · Cited by 150 · cited 2×
“Phosphorylation of REDD1 leads to its proteasomal degradation and to the recovery of mTOR signaling [103].”
Backgroundβ-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive Behaviors
Gould, T. D., Einat, H., O’Donnell, K. C., Picchini, A. M., Schloesser, R. J., & Manji, H. K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301338 · Cited by 148 · cited 1×
“This is in line with an observation that overexpression of β-catenin mimics the effect of lithium [114].”
BackgroundMöller, H.-J., Volz, H.-P., Reimann, I. W., & Stoll, K.-D. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00011 · Cited by 147 · cited 1×
“2–50 nM [172]) and acts as their agonist [173].”
BackgroundJang, S.-W., Liu, X., Chan, C.-B., Weinshenker, D., Hall, R. A., Xiao, G., & Ye, K. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.010 · Cited by 144 · cited 1×
“Moreover, amitriptyline acts as an agonist of TrkB in the absence of its ligands [168].”
BackgroundLi, L., Stefan, M. I., & Novère, N. G. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043810 · Cited by 134 · cited 1×
“In contrast, modest [Ca]c causes calcineurin activation [25].”
Backgroundp11 (S100A10) — an inducible adaptor protein that modulates neuronal functions
Svenningsson, P., & Greengard, P. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.10.001 · Cited by 130 · cited 1×
“It modulates signal transduction associated with serotonin receptors (especially 5-HT1BR) stimulation [99] and increases plasma membrane localization of 5-HT1BRs [100].”
BackgroundASsociation of gsk3β polymorphisms with brain structural changes in major depressive disorder
Inkster, B., Nichols, T. E., Saemann, P. G., Auer, D. P., Holsboer, F., Muglia, P., & Matthews, P. M. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.70 · Cited by 127 · cited 1×
“rs6438552 has been associated with a lowered volume of grey matter both in right and in left superior temporal gyri, and right hippocampus of MDD patients [58].”
BackgroundGlycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer
Nagini, S., Sophia, J., & Mishra, R. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.12.010 · Cited by 123
Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
Duda, P., Wiśniewski, J., Wójtowicz, T., Wójcicka, O., Jaśkiewicz, M., Drulis-Fajdasz, D., Rakus, D., McCubrey, J. A., & Gizak, A. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1526925 · Cited by 123 · cited 6×
“Both the TrkB/MEK/ERK and TrkB/PI3K/AKT pathways can activate mTOR and inactivate GSK3β [13,204].”
BackgroundInfluentialSelf-citationBychkov, E., Ahmed, M. R., Dalby, K. N., & Gurevich, E. V. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04586.x · Cited by 122 · cited 1×
“The depletion of DA has the opposite effect [156].”
BackgroundParadoxical Striatal Cellular Signaling Responses to Psychostimulants in Hyperactive Mice
Beaulieu, J.-M., Sotnikova, T. D., Gainetdinov, R. R., & Caron, M. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606062200 · Cited by 116 · cited 6×
“Constant hyper-dopaminergy in mice lacking DA transporter (DAT), which removes DA from the synaptic cleft, leads to a reduction in AKT activity and an increased activity of GSK3α/β [154].”
BackgroundInfluentialExpression analysis of glycogen synthase kinase‐3 in human tissues
Lau, K. ‐., Miller, C. C. J., Anderton, B. H., & Shaw, P. ‐. (1999) · The Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00083.x · Cited by 113 · cited 1×
“In the human brain, the β isozyme predominates [9].”
BackgroundDifferential effects of antidepressant drugs on mTOR signalling in rat hippocampal neurons
Park, S. W., Lee, J. G., Seo, M. K., Lee, C. H., Cho, H. Y., Lee, B. J., Seol, W., & Kim, Y. H. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000534 · Cited by 111 · cited 1×
“Tranylcypromine, a nonselective MAO-A and MAO-B inhibitor, enhances the activity of AKT and stimulates the expression of BDNF [191,192].”
BackgroundO’Brien, W. T., Huang, J., Buccafusca, R., Garskof, J., Valvezan, A. J., Berry, G. T., & Klein, P. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45194 · Cited by 109 · cited 2×
“Moreover, heterozygous loss of Gsk3β causes behavioral defects that mimic the action of lithium [67], whereas transgenic expression of Gsk3β in Gsk3β+/− heterozygotes reverses these defects [68].”
BackgroundClassics in Chemical Neuroscience: Ketamine
Tyler, M. W., Yourish, H. B., Ionescu, D. F., & Haggarty, S. J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00074 · Cited by 106 · cited 1×
“Ketamine can block the activity of NMDA receptors [203].”
BackgroundMAPK signaling correlates with the antidepressant effects of ketamine
Réus, G. Z., Vieira, F. G., Abelaira, H. M., Michels, M., Tomaz, D. B., dos Santos, M. A. B., Carlessi, A. S., Neotti, M. V., Matias, B. I., da Luz, J. R., et al. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.04.010 · Cited by 104 · cited 5×
“BDNF is a ligand for tropomyosin receptor kinase B (TrkB), the stimulation of which leads to the activation of PI3K/AKT and ERK1/2 signaling pathways [91].”
BackgroundInfluentialRegulation of GSK3 isoforms by phosphatases PP1 and PP2A
Hernández, F., Langa, E., Cuadros, R., Ávila, J., & Villanueva, N. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0544-0 · Cited by 103 · cited 1×
“On the other hand, dephosphorylation of Ser9 by protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A), and protein phosphatase 2B (PP2B, calcineurin) directly activates GSK3β [23].”
BackgroundKarege, F., Perroud, N. A., Burkhardt, S., Fernandez, R. J., Ballmann, E., Harpe, R. L., & Malafosse, A. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.09.024 · Cited by 103 · cited 2×
“This suggests a role of GSK3β in MDD but not in suicide per se [40,41].”
BackgroundIncreased Temporal Cortex ER Stress Proteins in Depressed Subjects Who Died by Suicide
Bown, C. D., Wang, J. F., MacQueen, G., & Young, L. T. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00091-3 · Cited by 102 · cited 1×
“The signs of ER-stress-induced UPR have been found in brains of depressed patients who died by suicide [109].”
BackgroundInhibitory Phosphorylation of GSK-3 by CaMKII Couples Depolarization to Neuronal Survival
Song, B., Lai, B., Zheng, Z., Zhang, Y., Luo, J., Wang, C., Chen, Y., Woodgett, J. R., & Li, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.130351 · Cited by 99 · cited 1×
“CaMK2 stimulates its phosphorylation and thus, inhibits GSK3β, while calcineurin induces its dephosphorylation and activates the kinase [22,26].”
BackgroundA Role for p11 in the Antidepressant Action of Brain-Derived Neurotrophic Factor
Warner-Schmidt, J. L., Chen, E. Y., Zhang, X., Marshall, J. J., Morozov, A., Svenningsson, P., & Greengard, P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.029 · Cited by 97 · cited 2×
“One of the downstream targets of BDNF is p11 (also called S100A10), the expression of which is positively regulated by BDNF through TrkB and via the MAPK/ERK signaling pathway [98].”
BackgroundGriebel, G., Stemmelin, J., Lopez-Grancha, M., Boulay, D., Boquet, G., Slowinski, F., Pichat, P., Beeské, S., Tanaka, S., Mori, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54557-5 · Cited by 97 · cited 1×
“In turn, an ATP-competitive GSK3β inhibitor SB216763 has been found to increase anti-depressant responses in the forced swim test [71], whereas SAR502250 improved the stress-induced physical state in the chronic mild stress test in mice [72].”
BackgroundRole of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogens
Cortés-Vieyra, R., Bravo-Patiño, A., Valdez-Alarcón, J. J., Cajero-Juárez, M., Finlay, B. B., & Baizabal-Aguirre, V. M. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-23 · Cited by 96 · cited 1×
“The role of GSK3β in the modulation of the inflammatory response is as complex as the inflammatory transduction signal pathway itself [146].”
BackgroundMoriguchi, S., Shinoda, Y., Yamamoto, Y., Sasaki, Y., Miyajima, K., Tagashira, H., & Fukunaga, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060863 · Cited by 94 · cited 1×
“However, dehydroepiandrosterone, the most abundant neurosterol in the central nervous system, improves cognitive function, ameliorates depressive-like behaviors, and stimulates neurogenesis in the dentate gyrus, increasing the activity of AKT and phosphorylation of the GSK3β Ser9 residue via σ1 receptors [174].”
BackgroundWnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic Implications
Muneer, A. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.2.100 · Cited by 94
Regulation of AMPA Receptor Trafficking and Function by Glycogen Synthase Kinase 3
Wei, J., Liu, W., & Yan, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121376 · Cited by 93 · cited 1×
“As a result, dephosphorylated (and activated) GSK3β phosphorylates postsynaptic density protein 95 (PSD95) and kinesin light chain 2 which regulates AMPARs internalization [28].”
BackgroundUrs, N. M., Snyder, J. C., Jacobsen, J. P. R., Peterson, S. M., & Caron, M. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215489109 · Cited by 91
Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders
Albayrak, Y., & Hashimoto, K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50174-1_11 · Cited by 90 · cited 1×
“They also act as agonists and antagonists of σ1 receptors (only sertraline is a σ1 receptor antagonist) [175].”
BackgroundGlycogen Synthase Kinase 3 Beta (GSK3β) Phosphorylates the RNAase III Enzyme Drosha at S300 and S302
Tang, X., Li, M., Tucker, L. D., & Ramratnam, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020391 · Cited by 89 · cited 3×
“The first step of miRNA maturation occurs in the nucleus and engages the ribonuclease III enzyme called Drosha.”
BackgroundInfluentialERK1/2 Antagonizes Glycogen Synthase Kinase-3β-induced Apoptosis in Cortical Neurons
Hetman, M., Hsuan, S.-L., Habas, A., Higgins, M. J., & Xia, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111227200 · Cited by 88 · cited 1×
“Both of these pathways reduce the activity of GSK3β, but only PI3K/AKT acts through phosphorylation of Ser9 [92,93].”
BackgroundSerum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202
Gheysarzadeh, A., Sadeghifard, N., Afraidooni, L., Pooyan, F., Mofid, M., Valadbeigi, H., Bakhtiari, H., & Keikhavani, S. (2018) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_879_17 · Cited by 87 · cited 1×
“Both the miRs are decreased in the blood of MDD patients [120], which corresponds to an increased level of GSK3β [39].”
BackgroundChen, M. J., & Russo-Neustadt, A. A. (2007) · Growth Factors · doi:10.1080/08977190701602329 · Cited by 86 · cited 2×
“It stimulates the overexpression of BDNF and the upregulation of AKT [192].”
BackgroundRoh, M., Eom, T.-Y., Zmijewska, A. A., Sarno, P. D., Roth, K. A., & Jope, R. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.039 · Cited by 83 · cited 1×
“The first described TCA is imipramine, which increases Ser9 phosphorylation of GSK3β in the mouse cerebral cortex, hippocampus, and striatum [163].”
BackgroundNatural and synthetic bioactive inhibitors of glycogen synthase kinase
Khan, I., Tantray, M. A., Alam, M. S., & Hamid, H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.058 · Cited by 82 · cited 1×
“GSK3β inhibitors can be classified into three categories: non-ATP-competitive, ATP-competitive, and substrate competitive inhibitors [69].”
BackgroundMeares, G. P., Mines, M. A., Beurel, E., Eom, T.-Y., Song, L., Zmijewska, A. A., & Jope, R. S. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.012 · Cited by 80 · cited 12×
“UPR is a cellular stress response mechanism activated upon the accumulation of misfolded proteins in the ER.”
BackgroundInfluentialThe antidepressant sertraline downregulates Akt and has activity against melanoma cells
Reddy, K. K., Lefkove, B., Chen, L. B., Govindarajan, B., Carracedo, A., Velasco, G., Carrillo, C. O., Bhandarkar, S. S., Owens, M. J., Mechta‐Grigoriou, F., et al. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00481.x · Cited by 78
Calcineurin dephosphorylates glycogen synthase kinase‐3 beta at serine‐9 in neuroblast‐derived cells
Kim, Y., Lee, Y., Seo, M., Kim, S., Lee, J., Youn, H., Kim, Y., & Juhnn, Y. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06318.x · Cited by 77 · cited 1×
“CaMK2 stimulates its phosphorylation and thus, inhibits GSK3β, while calcineurin induces its dephosphorylation and activates the kinase [22,26].”
BackgroundPyko, I. V., Nakada, M., Sabit, H., Teng, L., Furuyama, N., Hayashi, Y., Kawakami, K., Minamoto, T., Fedulau, A., & Hamada, J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt182 · Cited by 76 · cited 3×
“This upregulates the expression of DNMT3a [129].”
Beurel, E., Grieco, S. F., Amadei, C., Downey, K., & Jope, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12436 · Cited by 76 · cited 2×
“It has been shown that inhibition of GSK3 is necessary for the rapid anti-depressant action of ketamine in mice [209], whereas knock-in mice with constitutively active GSK3β are insensitive to the anti-depressant action of ketamine [208].”
BackgroundDual Regulation of Glycogen Synthase Kinase-3β by the α1A-Adrenergic Receptor
Ballou, L. M., Tian, P.-Y., Lin, H.-Y., Jiang, Y.-P., & Lin, R. Z. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103480200 · Cited by 72 · cited 5×
“Their action is associated with modulation of PKA, PKC, and PLC activity.”
BackgroundInfluentialLin, C.-J., Robert, F., Sukarieh, R., Michnick, S., & Pelletier, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4072 · Cited by 69 · cited 1×
“stimulates overexpression of REDD1 and inhibits mTOR [183].”
BackgroundGSK3β isoform‐selective regulation of depression, memory and hippocampal cell proliferation
Pardo, M., Abrial, E., Jope, R. S., & Beurel, E. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12283 · Cited by 68 · cited 1×
“Later, using GSK3β knock-in mice, it has been established that increased activity of the β isozyme of GSK3 is sufficient to impair mood regulation in learned helplessness model of depressive-like behavior, whereas GSK3α activity alone does not impair this process [65].”
BackgroundGlycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission
Polter, A. M., & Li, X. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00031 · Cited by 67
Functional significance of glycogen synthase kinase-3 regulation by serotonin
Polter, A. M., Yang, S., Jope, R. S., & Li, X. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.09.009 · Cited by 66 · cited 1×
“Fluoxetine increases the inhibitory phosphorylation of GSK3β in mice hippocampi, and the anti-depressant effect of fluoxetine is diminished when the phosphorylation is hindered [176].”
BackgroundMorales‐Medina, J. C., Juárez, I., Venancio-García, E., Cabrera, S. N., Ménard, C., Yu, W., Flores, G., Mechawar, N., & Quirion, R. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.037 · Cited by 65
Crofton, E. J., Nenov, M. N., Zhang, Y., Scala, F., Page, S. A., McCue, D. L., Li, D., Hommel, J. D., Laezza, F., & Green, T. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.020 · Cited by 64 · cited 1×
“, found that the knockdown of GSK3β in the nucleus accumbens shell increases cocaine self-administration and depression-like behavior in social contact tests in rats [47,48].”
BackgroundFKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications
Gassen, N. C., Hartmann, J., Zannas, A. S., Kretzschmar, A., Zschocke, J., Maccarrone, G., Hafner, K., Zellner, A., Kollmannsberger, L. K., Wagner, K. V., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.38 · Cited by 62 · cited 1×
“The same effect as fluvoxamine [179], whereas paroxetine inhibits GSK3β via functional synergism with FK506 binding protein 51 [180].”
BackgroundCostemale-Lacoste, J.-F., Guilloux, J., & Gaillard, R. (2016) · L Encéphale · doi:10.1016/j.encep.2016.02.003 · Cited by 61 · cited 1×
“Although the monoaminergic hypothesis has led to the invention of many successful therapeutic strategies based on the elevation of levels of NA and 5-HT in the synaptic cleft, it does not explain the anti-depressant effect of lithium and the rapid action of ketamine in the treatment of mood disorders [6].”
BackgroundTimberlake, M. A., & Dwivedi, Y. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0241-z · Cited by 61
Engel, D. F., Zomkowski, A. D. E., Lieberknecht, V., Rodrigues, A. L. S., & Gabilan, N. H. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.02.013 · Cited by 60
Warren, B. L., Sial, O. K., Alcantara, L. F., Greenwood, M. A., Brewer, J. S., Rozofsky, J. P., Parise, E. M., & Bolaños-Guzmán, C. A. (2014) · Developmental Neuroscience · doi:10.1159/000362875 · Cited by 58 · cited 2×
“Simultaneously, atrophy of the PFC and hippocampus, and increased synaptogenesis in limbic regions, are observed in depressed individuals [75,77,81,82].”
BackgroundZhang, K., Yang, C., Xu, Y. J., Sun, N., Yang, H., Liu, J., Xu, Q., & Shen, Y. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0360-4 · Cited by 57 · cited 1×
“Single nucleotide polymorphism (SNP) rs6782799 in GSK3β gene has been demonstrated to be important for susceptibility to MDD by modification of the relationship between negative life events and depression [54,55].”
BackgroundO’Leary, A., Kõiv, K., Hinsley, T. A., Brass, A., & Harro, J. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.09.005 · Cited by 54 · cited 1×
“The increase on GSK3β activity has also been found in platelets of depressed patients [42,43], whereas the GSK3β gene expression was upregulated in such brain structures as the frontal cortex, raphe, and hippocampus in the rat model of depression [44].”
BackgroundDual effects of increased glycogen synthase kinase-3β activity on adult neurogenesis
Fuster-Matanzo, A., Llorens-Martín, M., Sirerol-Piquer, M. S., García-Verdugo, J. M., Avila, J., & Hernández, F. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds533 · Cited by 54 · cited 1×
“Moreover, in vivo overexpression of GSK3β reduces neurogenesis in adult hippocampus [96] and induces pro-depressant-like events [97].”
BackgroundActivity-dependent regulation of dendritic growth and maintenance by glycogen synthase kinase 3β
Rui, Y., Myers, K. R., Yu, K., Wise, A., De Blas, A. L., Hartzell, H. C., & Zheng, J. Q. (2013) · Nature Communications · doi:10.1038/ncomms3628 · Cited by 52 · cited 1×
“The Ser9 of GSK3β is highly phosphorylated upon stimulation of synaptogenesis, and the inhibition of the kinase is required for dendritic growth and arborization, whereas an increase in its activity leads to marked shrinkage of dendrites [94,95].”
BackgroundDiniz, B. S., Talib, L. L., Joaquim, H. P. G., de Paula, V. D. J. R., Gattaz, W. F., & Forlenza, O. V. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.551408 · Cited by 52
Saus, E., Soria, V., Escaramís, G., Crespo, J. M., Valero, J., Gutiérrez‐Zotes, A., Martorell, L., Vilella, E., Menchón, J. M., Estivill, X., et al. (2010) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00617.x · Cited by 51 · cited 1×
“Its C/C and C/G genotypes are associated with the late age of onset (about 46 and 41 years old on average, respectively), whereas its G/G genotype with the early (about 28 years old on average) onset of depression [56].”
BackgroundUnfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation
Nijholt, D. A. T., Nölle, A., van Haastert, E. S., Edelijn, H., Toonen, R. F. G., Hoozemans, J. J. M., & Scheper, W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.008 · Cited by 51
Omata, N., Chiu, C.-T., Moya, P. R., Leng, Y., Wang, Z., Hunsberger, J. G., Leeds, P., & Chuang, D.-M. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000726 · Cited by 50 · cited 1×
“Bilateral intra-hippocampal injections of lentivirus expressing shRNA anti-Gsk3β induce an antidepressant-like effect in chronically stressed mice in the forced swim and tail suspension tests [66].”
BackgroundAtomoxetine Prevents Dexamethasone-Induced Skeletal Muscle Atrophy in Mice
Jesinkey, S. R., Korrapati, M. C., Rasbach, K. A., Beeson, C., & Schnellmann, R. G. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.217380 · Cited by 50 · cited 1×
“Members of the SSNRIs group, atomoxetine and milnacipran, induce AKT by increasing its activatory phosphorylation [184,185], whereas duloxetine stimulates expression of AKT and inhibits expression of both GSK3 isozymes [186].”
BackgroundShadfar, S., Kim, Y.-G., Katila, N., Neupane, S., Ojha, U., Bhurtel, S., Srivastav, S., Jeong, G., Park, P., Hong, J. T., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0342-0 · Cited by 48 · cited 1×
“Members of the SSNRIs group, atomoxetine and milnacipran, induce AKT by increasing its activatory phosphorylation [184,185], whereas duloxetine stimulates expression of AKT and inhibits expression of both GSK3 isozymes [186].”
BackgroundChen, P., Lao, C. L., & Chen, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04203.x · Cited by 47
Yang, C., Xu, Y. J., Sun, N., Ren, Y., Liu, Z., Cao, X., & Zhang, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.079 · Cited by 47 · cited 1×
“Single nucleotide polymorphism (SNP) rs6782799 in GSK3β gene has been demonstrated to be important for susceptibility to MDD by modification of the relationship between negative life events and depression [54,55].”
BackgroundSugama, S., & Kakinuma, Y. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.04.008 · Cited by 47 · cited 1×
“However, chronic stress can also lead to atrophy of the ventral tegmental area system [50].”
BackgroundChen, Y. C., Tan, Q., Dang, W., Wang, H. N., Zhang, R. B., Li, Z. Y., Lin, H., & Liu, R. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.03.004 · Cited by 46 · cited 1×
“Citalopram and its (S)-stereoisomer escitalopram both stimulate the inhibitory phosphorylation of GSK3β [177,178].”
BackgroundGSK3β Inhibition Promotes Synaptogenesis in Drosophila and Mammalian Neurons
Cuesto, G., Jordán-Álvarez, S., Enríquez-Barreto, L., Ferrús, A., Morales, M., & Acebes, Á. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118475 · Cited by 46 · cited 1×
“The Ser9 of GSK3β is highly phosphorylated upon stimulation of synaptogenesis, and the inhibition of the kinase is required for dendritic growth and arborization, whereas an increase in its activity leads to marked shrinkage of dendrites [94,95].”
BackgroundAgomelatine, a melatonin agonist with antidepressant properties
Dubovsky, S. L., & Warren, C. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903292634 · Cited by 44 · cited 1×
“Agomelatine also acts as an antagonist of 5-HT2CR [196].”
BackgroundTka, K. H. A., Mahfoudh-Boussaid, A., Zaoualí, M. A., Kammoun, R., Béjaoui, M., Ghoul, S., Roselló‐Catafau, J., & Abdennebi, H. B. (2015) · Analytical Cellular Pathology · doi:10.1155/2015/635172 · Cited by 42
Wu, Y., Liu, F., Liu, Y., Liu, X., Ai, Z., Guo, Z., & Zhang, Y. (2015) · Scientific Reports · doi:10.1038/srep08666 · Cited by 38 · cited 1×
“Inactivation of GSK3β results in the inhibition of maturation of the miR-302-367 cluster activated by WNT/β-catenin signaling, and miR-181 family [119].”
BackgroundBrain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice
Mines, M. A., & Jope, R. S. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.03.001 · Cited by 38 · cited 1×
“A chronic administration of methylphenidate increases activating phosphorylation of AKT and inhibits GSK3β in the cerebral cortex in mice [194].”
BackgroundDaniele, S., Zappelli, E., & Martini, C. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0446-x · Cited by 38 · cited 1×
“Trazodone slightly elevates the concentration of 5-HT in synaptic clefts and promotes AKT activity and GSK3β inactivation [197].”
BackgroundMoclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice.
Li, Y., Zhang, Y., Liu, Y., Wang, H., Yuan, L., & Luo, Z.-P. (2004) · PubMed · Cited by 38
Zhang, K., Song, X., Xu, Y. J., Li, X., Liu, P., Sun, N., Zhao, X., Liu, Z., Xie, Z., & Peng, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.033 · Cited by 36 · cited 1×
“Moreover, in vivo overexpression of GSK3β reduces neurogenesis in adult hippocampus [96] and induces pro-depressant-like events [97].”
BackgroundKambe, Y., & Miyata, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.006 · Cited by 30 · cited 1×
“It has been shown that UPR may be active also in mitochondria of the murine model of depression [111], which points to a new mechanism involved in the development of this disease.”
BackgroundAznar, S., Klein, A. B., Santini, M. A., Knudsen, G. M., Henn, F., Gass, P., & Vollmayr, B. (2010) · Synapse · doi:10.1002/syn.20773 · Cited by 30 · cited 2×
“In a rat model of depression, the concentration of BDNF is reduced in the hippocampus [87], and the release of BDNF seems to mediate the rapid action of ketamine in PFC [88].”
BackgroundActivation of GABAB receptors inhibits protein kinase B /Glycogen Synthase Kinase 3 signaling
Lu, F. F., Su, P., Liu, F., & Daskalakis, Z. J. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-41 · Cited by 30
Rao, T. S., Cler, J. A., Mick, S. J., Dilworth, V., Contreras, P. C., IYENGAR, S., & WOOD, P. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90044-r · Cited by 27 · cited 1×
“2–50 nM [172]) and acts as their agonist [173].”
BackgroundMorioka, N., Abe, H., Araki, R., Matsumoto, N., Zhang, F. F., Nakamura, Y., Hisaoka‐Nakashima, K., & Nakata, Y. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24452 · Cited by 25 · cited 7×
“Their action is associated with modulation of PKA, PKC, and PLC activity.”
BackgroundInfluentialRen, Q., Wang, Y., Gong, W.-G., Xu, L., & Zhang, Z. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143012 · Cited by 25 · cited 2×
“Citalopram and its (S)-stereoisomer escitalopram both stimulate the inhibitory phosphorylation of GSK3β [177,178].”
BackgroundCong, W., Chadwick, W., Wang, R., Daimon, C. M., Cai, H., Amma, J., Wood, W. H., Becker, K. G., Martin, B., & Maudsley, S. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.588608 · Cited by 23 · cited 1×
“3 nM and 19–35 nM [164], respectively), enhances phosphorylation of the GSK3β Ser9 residue [167].”
Background
Cited by
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
Molecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
“Polyamines such as spermidine, spermine, putrescine and agmatine are short, aliphatic amines that impact several pathways and synaptic activity by a variety of mechanisms; the impacted molecules and pathways include almost all systems mentioned in this review, e.g., Na+-, K+- and Ca2+-channels, 5-HT, NMDA, AMPA, kaina…”
BackgroundXiao, Z., Cao, Z., Yang, J., Jia, Z., Du, Y., Sun, G., Lu, Y. F., & Pei, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114594 · Cited by 76
Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases
Marosi, M., Arman, P., Aceto, G., D’Ascenzo, M., & Laezza, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084413 · Cited by 46
“Herein, we provide an overview of the mechanisms by which GSK3β mediates direct and indirect effects on Nav and Kv channels with implications for neuronal excitability, plasticity, and ultimately vulnerability to neuropsychiatric disorders [34,53,56,58,59].”
BackgroundUrkon, M., Ferencz, E., Szász, J. A., Szabó, M. I. M., Orbán-Kis, K., Szatmári, S., & Nagy, E. E. (2025) · Pharmaceuticals · doi:10.3390/ph18050614 · Cited by 44
“In addition, enhanced BDNF signaling or TNF α reduction could also contribute to Akt/GSK-3 β regulation [185].”
Metadata
- Authors
- Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A.
- Affiliations
- University of Wrocław (PL)
- Corresponding author
- Duda, Przemysław
- Gizak, Agnieszka
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-03-16
- Volume
- 9
- Issue
- 3
- Pages
- 727
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7140610
- OpenAlex
- W3012493302
- Cited by
- 84
- References
- 211
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 11 · 2023: 12 · 2022: 12 · 2021: 11 · 2020: 3
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Polish Ministry of Science and Higher Education (UMO-2015/19/B/NZ1/00332)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- GSK3β, glycogen synthase kinase-3β, major depressive disorder, depression pathogenesis, antidepressant response, GSK-3β inhibitors, antidepressant mechanism, upstream regulators, brain regions, depression-like behavior
- MeSH terms
- Neuroprotection, Glycogen Synthase Kinase 3 beta, Animals, Brain, Major Depressive Disorder, Hippocampus, Humans, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.